Mounjaro Out-of-Pocket Cost: 9 Real Price Options (2026)

What does Mounjaro cost without insurance?

Walk into a pharmacy with a Mounjaro prescription and no discount card, and you'll pay around $1,088 for a 28-day supply. That figure holds across all six dose strengths — 2.5mg through 15mg — because Eli Lilly prices Mounjaro as a fixed monthly carton of four auto-injector pens, not by milligrams. At that rate, a full year of Mounjaro costs about $13,056.

GoodRx coupons exist for Mounjaro, but the savings are modest. Lilly's pharmacy contracts limit how much third-party discount programs can cut into the price. With a GoodRx coupon, you'll land between $1,029 and $1,088 per month depending on the pharmacy — Walmart tends to post the lowest rates, while CVS and Walgreens run slightly higher. That's roughly 0-5% off list. Check GoodRx directly for your ZIP code before filling, since pricing shifts week to week.

Eli Lilly Savings Card: who pays $25 vs $499/month?

The Mounjaro Savings Card from Eli Lilly is the most powerful discount available for commercially insured patients — but there are two very different tiers, and which one you land on depends on a single question: does your insurance plan cover Mounjaro?

• $25/month tier — Your commercial plan covers Mounjaro for type 2 diabetes, and your prescription matches FDA-approved labeling. Annual savings cap: $1,950. Card is good for up to 13 fills per calendar year.
• $499/month tier — You have commercial insurance, but your plan does NOT cover Mounjaro. Annual savings cap: $8,411. Still a significant discount from the $1,088 list price.
• Not eligible — Medicare, Medicaid, VA, TRICARE, and other government program beneficiaries cannot use the card. The card expires December 31, 2026.

The fine print matters: your prescription must be for an FDA-approved use. Mounjaro is approved for type 2 diabetes only. A prescription written explicitly for weight loss disqualifies you from the card — even if you happen to have type 2 diabetes alongside the weight concern. Your prescriber's documented indication is what the card program checks.

Mounjaro vs Zepbound: same molecule, very different price path

This is the most important thing to understand before your prescriber writes any tirzepatide prescription: Mounjaro and Zepbound are the same drug. Both contain tirzepatide, manufactured by Eli Lilly, at identical dose strengths. The only difference is their FDA approval. Mounjaro was approved in 2022 for type 2 diabetes. Zepbound arrived in 2023 with an approval for chronic weight management.

That single regulatory difference ripples through every cost calculation. Insurance covers medications by indication, not by molecule. A plan may cover Mounjaro for a T2D patient but deny the same drug under the Zepbound label for a patient whose only documented indication is obesity. And Medicare, by statute, cannot cover drugs prescribed solely for weight loss — meaning Mounjaro off-label for weight management gets zero Medicare coverage.

For women in perimenopause navigating metabolic changes — where weight management and insulin resistance often overlap — understanding which indication applies to your situation is a real conversation to have with your provider. If the primary goal is weight management and you're paying cash, Zepbound through LillyDirect is the smarter financial choice.

LillyDirect Zepbound self-pay: the cash-pay brand option

Eli Lilly sells Zepbound single-dose vials directly to cash-pay patients through LillyDirect at a dramatically reduced price: $299/month for 2.5mg, $399/month for 5mg, and $449/month for doses from 7.5mg through 15mg. These are real Zepbound — not compounded — dispensed through Lilly's partner pharmacy. The trade-off: you get vials instead of the pre-filled auto-injector pens, and you cannot bill insurance for these fills.

One catch on the higher-dose pricing: to maintain the $449/month rate at 7.5mg and above, you must refill within 45 days of your previous delivery. Miss that window and the price jumps to standard rates. Set a calendar reminder.

There is no equivalent self-pay vial program for the Mounjaro brand as of June 2026. If you're self-paying and want brand-name tirzepatide, Zepbound through LillyDirect is your path. See the full tirzepatide cost breakdown for a side-by-side comparison of both brands.

Compounded tirzepatide: lower cost, different legal landscape

When brand-name Zepbound and Mounjaro were in shortage, the FDA permitted compounding pharmacies to produce tirzepatide copies. That window closed. The FDA declared the tirzepatide shortage resolved in October 2024, ended enforcement discretion for 503B outsourcing facilities in March 2025, and ended it for 503A state-licensed pharmacies earlier that year.

Compounded tirzepatide is still technically available — but only through a narrow 503A exception that requires documented medical justification from your prescriber (such as an allergy to an inactive ingredient in the commercial product, or a specific clinical need the brand drug cannot meet). Cost savings alone does not qualify. As of mid-2026, several telehealth companies continue operating under this framework; the legal status remains contested, with Eli Lilly actively suing multiple telehealth providers over compounding practices.

If you're considering compounded tirzepatide, the practical question is not just price. It's whether your specific situation provides the documented medical justification the 503A pathway requires — and whether the pharmacy your provider uses is licensed, state-regulated, and operating transparently.

Mochi Health — compounded tirzepatide, ~$278/month

Mochi Health advertises compounded tirzepatide at $199/month for medication, but that number is incomplete. Mochi also charges a separate $79/month membership fee, billed as its own auto-renewing subscription. All-in, the real cost is closer to $278/month. The two subscriptions are intentionally separate — canceling one does not cancel the other, which is a frequent complaint in customer reviews of the company.

Mochi Health operates through 503A compounding pharmacies. Eli Lilly sued Mochi in 2025, alleging its compounded tirzepatide practices fall outside legitimate individualized compounding. The case is ongoing. Read the full Mochi Health review for the complete picture.

Henry Meds — compounded tirzepatide, $297-$349/month

Henry Meds prices compounded tirzepatide between $297 and $349 per month, with exact pricing dependent on your specific treatment plan. Unlike Mochi's split-bill structure, Henry Meds bundles provider visits, medication, and shipping into its quoted price. The catch: final pricing sits behind an intake quiz rather than on a public pricing page, which makes comparison shopping harder before you commit time to the onboarding process. See the Henry Meds review for a full assessment before starting.

Fridays — compounded tirzepatide, $240-$359/month

Fridays offers what is arguably the most transparent pricing structure of the three: $240/month on an annual plan, or $359/month on a month-to-month basis. The annual plan requires a 12-month commitment upfront. Both tiers include unlimited provider visits, a registered dietitian, nutrition coaching, and a fitness app — so it's an all-inclusive program rather than a medication-only service. Like all compounded drugs, it has not been reviewed by the FDA for safety, efficacy, or quality. Read the Fridays review to understand the full program before enrolling.

Does insurance cover Mounjaro for weight loss?

Almost certainly not — at least not if weight loss is the stated reason on the prescription. Mounjaro is FDA-approved for type 2 diabetes. When a plan covers it, coverage is tied to that indication. A prescription written for weight management, even off-label, gives most commercial insurers grounds to deny the claim.

Medicare cannot cover drugs prescribed solely for weight loss — that's statutory, not a plan choice. Medicare may cover Mounjaro for a beneficiary with documented type 2 diabetes if it's on the plan's formulary. As of July 1, 2026, a Medicare GLP-1 Bridge Program launched at $50/month for eligible beneficiaries — but initial availability is limited, and the broader expansion is scheduled for January 2027.

The cleaner path for women whose primary goal is weight management: ask your provider about Zepbound, which carries the obesity indication and gives you access to on-label insurance coverage, LillyDirect self-pay pricing, and Lilly savings programs designed for weight management. See the GLP-1 cost overview for how costs compare across the full category.

Patient assistance: can you get Mounjaro free?

Eli Lilly runs the Lilly Cares Foundation, a patient assistance program that can provide Mounjaro at no cost to qualifying patients. Eligibility requires all three of the following: an active Mounjaro prescription for type 2 diabetes, no current enrollment in Medicaid or Medicare, and household income at or below 400% of the federal poverty level (roughly $63,840 per year for a single person in 2026). Applications go through lillycares.com; approval typically takes two to four weeks, and approved patients receive a supply shipped to their prescriber's office.

Annual cost math: what Mounjaro actually costs over a year

• Retail, no discount: ~$13,056/year ($1,088 x 12)
• GoodRx coupon: ~$12,348-$13,056/year ($1,029-$1,088 x 12)
• Lilly Savings Card (insured, covered): ~$300/year ($25 x 12)
• Lilly Savings Card (insured, not covered): ~$5,988/year ($499 x 12)
• LillyDirect Zepbound, starting dose (2.5mg): ~$3,588/year ($299 x 12)
• LillyDirect Zepbound, maintenance (7.5-15mg): ~$5,388/year ($449 x 12)
• Mochi Health compounded (all-in): ~$3,336/year ($278 x 12)
• Henry Meds compounded: ~$3,564-$4,188/year ($297-$349 x 12)
• Fridays compounded, annual plan: ~$2,880/year ($240 x 12)

The gap between the cheapest insured path ($300/year) and full retail ($13,056/year) is nearly $13,000 annually — which is why verifying your coverage and savings card eligibility before the first fill matters so much. For a full breakdown of compounded vs brand pricing across providers, the cheapest tirzepatide page runs those numbers side by side.